Literature DB >> 18443107

Species distribution and in vitro antifungal susceptibility patterns of 75 clinical isolates of Fusarium spp. from northern Italy.

Anna Maria Tortorano1, Anna Prigitano, Giovanna Dho, Maria Carmela Esposto, Claudia Gianni, Anna Grancini, Cristina Ossi, Maria Anna Viviani.   

Abstract

Fusarium isolates from 75 Italian patients were identified by molecular methods, and their susceptibilities to antifungals were tested in vitro. Fusarium verticillioides was the species most frequently isolated from deep-seated infections, and F. solani was the species most frequently isolated from superficial infections. F. solani isolates showed high azole MICs, while F. verticillioides isolates showed low posaconazole MICs.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18443107      PMCID： PMC2443921          DOI： 10.1128/AAC.00272-08

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  10 in total

1.  In vitro activities of investigational triazoles against Fusarium species: effects of inoculum size and incubation time on broth microdilution susceptibility test results.

Authors:  Niki I Paphitou; Luis Ostrosky-Zeichner; Victor L Paetznick; Jose R Rodriguez; Enuo Chen; John H Rex
Journal:  Antimicrob Agents Chemother       Date:  2002-10       Impact factor: 5.191

2.  Treatment of non-Aspergillus moulds in immunocompromised patients, with amphotericin B lipid complex.

Authors:  John R Perfect
Journal:  Clin Infect Dis       Date:  2005-05-01       Impact factor: 9.079

3.  Use of the Diversi Lab System for species and strain differentiation of Fusarium species isolates.

Authors:  M Healy; K Reece; D Walton; J Huong; S Frye; I I Raad; D P Kontoyiannis
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

4.  Universal in vitro antifungal resistance of genetic clades of the Fusarium solani species complex.

Authors:  Mónica Azor; Josepa Gené; Josep Cano; Josep Guarro
Journal:  Antimicrob Agents Chemother       Date:  2007-01-12       Impact factor: 5.191

5.  Multiple evolutionary origins of the fungus causing Panama disease of banana: concordant evidence from nuclear and mitochondrial gene genealogies.

Authors:  K O'Donnell; H C Kistler; E Cigelnik; R C Ploetz
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-03       Impact factor: 11.205

6.  Microdilution susceptibility testing of amphotericin B, itraconazole, and voriconazole against clinical isolates of Aspergillus and Fusarium species.

Authors:  S Arikan; M Lozano-Chiu; V Paetznick; S Nangia; J H Rex
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

7.  Voriconazole treatment for less-common, emerging, or refractory fungal infections.

Authors:  John R Perfect; Kieren A Marr; Thomas J Walsh; Richard N Greenberg; Bertrand DuPont; Juliàn de la Torre-Cisneros; Gudrun Just-Nübling; Haran T Schlamm; Irja Lutsar; Ana Espinel-Ingroff; Elizabeth Johnson
Journal:  Clin Infect Dis       Date:  2003-04-22       Impact factor: 9.079

8.  Posaconazole as salvage treatment for invasive fusariosis in patients with underlying hematologic malignancy and other conditions.

Authors:  Issam I Raad; Ray Y Hachem; Raoul Herbrecht; John R Graybill; Roberta Hare; Gavin Corcoran; Dimitrios P Kontoyiannis
Journal:  Clin Infect Dis       Date:  2006-04-11       Impact factor: 9.079

9.  Cutaneous infection by Fusarium species in healthy and immunocompromised hosts: implications for diagnosis and management.

Authors:  Marcio Nucci; Elias Anaissie
Journal:  Clin Infect Dis       Date:  2002-09-18       Impact factor: 9.079

Review 10.  Fusarium infections in immunocompromised patients.

Authors:  Marcio Nucci; Elias Anaissie
Journal:  Clin Microbiol Rev       Date:  2007-10       Impact factor: 26.132
  10 in total
  34 in total

1.  Cross-reactivity of Fusarium spp. in the Aspergillus Galactomannan enzyme-linked immunosorbent assay.

Authors:  Anna Maria Tortorano; Maria Carmela Esposto; Anna Prigitano; Anna Grancini; Cristina Ossi; Caterina Cavanna; Giuliana Lo Cascio
Journal:  J Clin Microbiol       Date:  2012-01-11       Impact factor: 5.948

2.  Internet-accessible DNA sequence database for identifying fusaria from human and animal infections.

Authors:  Kerry O'Donnell; Deanna A Sutton; Michael G Rinaldi; Brice A J Sarver; S Arunmozhi Balajee; Hans-Josef Schroers; Richard C Summerbell; Vincent A R G Robert; Pedro W Crous; Ning Zhang; Takayuki Aoki; Kyongyong Jung; Jongsun Park; Yong-Hwan Lee; Seogchan Kang; Bongsoo Park; David M Geiser
Journal:  J Clin Microbiol       Date:  2010-08-04       Impact factor: 5.948

3.  Skin nodules in a patient with acute lymphoblastic leukaemia.

Authors:  Lenaïg Le Clech; Pascal Hutin; Solène Le Gal; Gaëlle Guillerm
Journal:  BMJ Case Rep       Date:  2014-01-09

4.  Amphotericin B and voriconazole susceptibility profiles for the Fusarium solani species complex: comparison between the E-test and CLSI M38-A2 microdilution methodology.

Authors:  A Debourgogne; S de Hoog; A Lozniewski; M Machouart
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-07-09       Impact factor: 3.267

5.  Use of matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of molds of the Fusarium genus.

Authors:  David Triest; Dirk Stubbe; Koen De Cremer; Denis Piérard; Anne-Cécile Normand; Renaud Piarroux; Monique Detandt; Marijke Hendrickx
Journal:  J Clin Microbiol       Date:  2014-11-19       Impact factor: 5.948

Review 6.  Fusarium infection in lung transplant patients: report of 6 cases and review of the literature.

Authors:  Herman A Carneiro; Jeffrey J Coleman; Alejandro Restrepo; Eleftherios Mylonakis
Journal:  Medicine (Baltimore)       Date:  2011-01       Impact factor: 1.889

7.  Interactions between triazoles and amphotericin B in treatment of disseminated murine infection by Fusarium oxysporum.

Authors:  Mery Ruíz-Cendoya; Marçal Mariné; M M Rodríguez; Josep Guarro
Journal:  Antimicrob Agents Chemother       Date:  2009-02-02       Impact factor: 5.191

Review 8.  Development, clinical utility, and place in therapy of posaconazole for prevention and treatment of invasive fungal infections.

Authors:  Emily Zoller; Connie Valente; Kyle Baker; Michael E Klepser
Journal:  Drug Des Devel Ther       Date:  2010-11-04       Impact factor: 4.162

9.  Disseminated amphotericin-resistant fusariosis in acute leukemia patients: report of two cases.

Authors:  Graziella Hanna Pereira; Derlene Attili de Angelis; Roosecelis Araujo Brasil; Marilena dos Anjos Martins; Dulcilena de Matos Castro e Silva; Maria Walderez Szeszs; Marcia de Souza Carvalho Melhem
Journal:  Mycopathologia       Date:  2012-10-18       Impact factor: 2.574

10.  Fusarium keratitis: genotyping, in vitro susceptibility and clinical outcomes.

Authors:  Rafael A Oechsler; Michael R Feilmeier; Darlene Miller; Wei Shi; Ana Luisa Hofling-Lima; Eduardo C Alfonso
Journal:  Cornea       Date:  2013-05       Impact factor: 2.651
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.